Women Who Rock™ Presented by Gibson Gives
5th Annual Live Benefit Concert Returns To Stage AE in Pittsburgh,
PA on October 15, 2022
Starring Multi-Platinum Recording Artist Jordin Sparks
Women in Music Unite to Rock the Future of Women’s Health
PITTSBURGH, PA (August 10, 2022) Women will rock Stage AE in Pittsburgh, PA on Saturday, October 15th as the 5th annual Women Who Rock Benefit Concert Presented by Gibson Gives returns as a live, in-person concert event. Women Who Rock connects through the power of music and helps educate, support and fund women-centric health research. This year’s annual Women Who Rock Benefit Concert on October 15th will star singer-songwriter and American Idol winner Jordin Sparks.
Jordin Sparks is a GRAMMY nominated, multi-platinum, singer/songwriter and actress who, in one of the show’s highest rated seasons, garnered worldwide attention as winner of season six American Idol. Sparks was just seventeen years old when she won the coveted title. Her self-titled debut went platinum, selling over two million copies worldwide. The first three singles of "Jordin Sparks" went top five and the album’s second single, “No Air” sold four million digital downloads. “No Air” has the distinction of being the third highest selling single by any American Idol contestant and is listed #27 in Billboard’s Top 40 Biggest Duets of All Time. Sparks’ second release, “Battlefield,” debuted on the Billboard Album chart at number seven. Cumulatively, Sparks popular singles have sold over 10 million digital tracks in the US. She considers philanthropy an integral part of her life and was recently profiled by CNN Heroes and Dress for Success for her charity work.
The 100% female-fronted music lineup will feature special guest triple-threat rock & roll singer-songwriter-guitarist and producer from Austin, TX Emily Wolfe. Wolfe is on a mission to breathe new life into classic rock & roll with her incendiary guitar chops and original songwriting. Wolfe’s creative songwriting, powerful lead vocals, and dominating guitar style has led her to share stages with Heart, The Struts, The Pretenders, White Reaper, Joan Jett, Catfish and the Bottlemen, and more Local performances on the 84 Lumber stage include Tiny Wars featuring guitarist Abby Krizner from IHEART RADIO 105.9 The X, and DJ Huny.
This year Dr. Lisa Rohan will receive the 2022 Women Who Rock Impact Award presented by Peoples, an Essential Utilities Company. Dr. Rohan has spent significant time developing products designed to prevent HIV infection in some of the world’s most vulnerable populations, particularly sub-Saharan Africa, where infection rates are highest and numbers continue to rise in the 15-24 female age group. Currently, human clinical trials are underway for a nasal spray developed by Dr. Rohan’s lab to provide 24-hour protection against COVID-19.
Host of IHEART RADIO 102.5 WDVE Michele Michaels will return for the fifth year in a row as the emcee. All proceeds from the Women Who Rock Benefit Concertsupport Magee-Womens Research Institute (MWRI)--the nation's largest research institute dedicated solely to life-saving women's health research.
Tickets for the 2022 Women Who Rock benefit concert go on sale Friday 8/12 at 10am ET: https://womenwhorock.info/pittsburgh-2022
Women Who Rock concert attendees will experience an interactive Beauty Bar offering free beauty perks and giveaways, social sharing Photo Booth, Silent Auction offering a chance to win one-of-a-kind experiences, a VIP Lounge & VIP gifting suite, pink carpet entrance, and a performance from the winner of the Women Who Rock Rising Star Contest.
October is Breast Cancer Awareness Month and Women’s health overall is underfunded and understudied. While most health research has sidestepped sexdifferences, Magee-Women’s Research Institute (MWRI) a 501c3 is based in Pittsburgh and the nation’s largest research institute dedicated solely to women’s health research and reproductive biology. MWRI’s current research includes 319 active studies spanning 292 different conditions with 162,000 clinical trial participants all over the world. MWRI’s areas of research cover breast and gynecologic cancers, reproductive biology, infectious diseases, the development of COVID-19 therapeutics and women-controlled HIV prevention, obstetric care for women with substance use disorder, postpartum depression, and more.
For fans that cannot attend the concert can support groundbreaking Breast Cancer and Women’s Health Research, Women Who Rock has debuted a new apparel and accessory collection. Items include the signature Women Who Rock lightning bolt pin, a Gibson X Women Who Rock guitar strap, guitar picks, T-shirts, onesies, tanks, and one-of-a-kind handmade jewelry. A portion of all proceeds from the Women Who Rock collection will fund the life-saving women’s health research at Magee-Womens Research Institute (MWRI). For more information on the Women Who Rock collection visit: https://womenwhorock.shop/ or donate directly: https://mageewomens.org/support.
Women Who Rock:
WOMENWHOROCK.INFO
Magee Womens Research Institute:
MAGEE WOMENS.ORG
Gibson Gives:
GIBSON GIVES.ORG
About Women Who Rock:
Women Who Rock connects through the power of music and helps educate, support and fund women-centric health research. As a female-founded company, WWR benefit concerts feature some of the brightest stars in music with a 100% female-fronted line-up and all proceeds benefiting life-saving women's health research at Magee-Womens Research Institute 501(c)(3) (MWRI). In addition to benefit concerts, Women Who Rock offers a full apparel and accessory line and hosts national campaigns, fundraisers, and pop-up events.
About Magee-Womens Research Institute (MWRI):
MWRI, a 501(c)(3), is based in Pittsburgh and the nation’s largest research institute dedicated solely to women’s health research and reproductive biology. MWRI’s current research includes 319 active studies spanning 292 different conditions with 162,000 clinical trial participants all over the world. MWRI’s areas of research cover breast and gynecologic cancers, reproductive biology, infectious diseases, the development of COVID-19 therapeutics and women-controlled HIV prevention, obstetric care for women with substance use disorder, postpartum depression, and more.